K12 Summit Educator Series: Bringing Bilingual Education to the Forefront

 

To kick off its first episode, host of K12 Summit’s new Educator Series podcast, JW Marshall, spoke with Dr. Liz Garza Garcia, president of BEAM with 16 years in education. While “Lizzie,” as nicknamed in college, would have never been associated with teaching, Garcia began mentoring and tutoring students in junior college. The experience of witnessing Spanish-speaking students fall behind because of the language barrier — not a knowledge gap — sparked her desire and passion for teaching.

Garcia’s education career progressed from tutor to educator and eventually administration; regardless of the stage, she focused her path on impacting bilingual and inequitable learning environments. “I went and decided to go into administration to be that administrator I never had,” Garcia explained.

After witnessing these unfair learning conditions, Garcia enrolled in a university — one that was up to par with her passion for equality and bilingual education — to receive a doctorate and gain even more credibility. While at her school of choice, Texas A&M Commerce, Garcia decided to focus on the evaluator’s feedback perspective from bilingual educators. The unfortunate realization of her studies? “Nothing really has changed and … more inequities have begun to open up and be masked [with Band-Aid fixes].”

For districts with bilingual programs, Garcia believes the educators should take the initiative to research the topic through getting involved with their local bilingual association (found at nabe.org) and discovering more resources at beamdfw.org.

“The great hope is that we’re going to be the mecca… Every single district that has a thriving dual-language program is trying to reach the same exact place — and that’s the mecca of dual-language programming.” Garcia, clearly passionate on the subject, is confident that if everyone has the same vision, then they will undoubtedly reach their goal while also exciting single-language students to learn an additional language to get in on the fun.

Follow us on social media for the latest updates in B2B!

Image

Latest

ESA
ESA Success Requires Strategy, Infrastructure, and Support Beyond Legislation
April 21, 2025

As education savings accounts (ESAs) gain traction across the United States, the conversation is shifting from policy debates to the complexities of implementation. Fueled by post-pandemic dissatisfaction with traditional school models and a desire for more customizable educational options, ESAs are being adopted in a growing number of states, often under “universal” frameworks. But…

Read More
supply chain data analytics
Supply Chain Data Analytics Fails Without Clean Data, Ventagium Delivers the Fix
April 21, 2025

Supply chain leaders face an overwhelming volume of siloed data across ERPs, TMS platforms, and warehouse systems, yet few know how to align it for smarter decisions. The stakes are rising fast. According to Capgemini’s 2024 report Data: A Powerful Ally in Tackling Scope 3 Emission Reduction Targets, 85% of organizations cite data access…

Read More
cancer immunotherapy
What’s Next in Preclinical Cancer Immunotherapy Research?
April 19, 2025

As the field of cancer immunotherapy rapidly evolves, researchers are turning to next-generation in vitro technologies to replicate the complexities of the tumor microenvironment with unprecedented fidelity. Organoid platforms and ex vivo patient-derived tissue models are transforming how scientists approach preclinical testing, offering deeper mechanistic insights and better predictive power for therapeutic response. With immunotherapies…

Read More
vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More